Evidence map›Paper›PMID 32336683›Full record

ArticleHaematologica2021

Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors.

Tomotaka Suzuki, Suguru Fukuhara, Junko Nomoto, Satoshi Yamashita, Akiko M Maeshima, Yuta Ito, Shunsuke Hatta, Sayako Yuda, Shinichi Makita, Wataru Munakata and 7 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Tomotaka SuzukiDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Suguru FukuharaDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Junko NomotoDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Satoshi YamashitaDepartment of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Akiko M MaeshimaDepartment of Pathology, National Cancer Center Hospital, Tokyo, Japan.
Yuta ItoDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Shunsuke HattaDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Sayako YudaDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Shinichi MakitaDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Wataru MunakataDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Tatsuya SuzukiDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Dai MaruyamaDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Hirokazu TaniguchiDepartment of Pathology, National Cancer Center Hospital, Tokyo, Japan.
Toshikazu UshijimaDepartment of Epigenomics, National Cancer Center Research Institute, Tokyo, Japan.
Koji IzutsuDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Kensei TobinaiDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Yukio KobayashiDepartment of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Tokyo National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsHumansRecurrence

Identifiers

PMID32336683
PMCPMC7849574
OpenAlexW3013931098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.